A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins.
暂无分享,去创建一个
Hongjun Bai | N. Michael | V. Dussupt | B. Slike | K. Modjarrad | M. Rolland | Zhanna Shubin | S. Krebs | Melanie Merbah | Suzanne E Wollen-Roberts | Yifan Li | Letzibeth Mendez-Rivera
[1] Weam I Zaky,et al. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor , 2020, Nature Medicine.
[2] B. Guy,et al. Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection. , 2019, Journal of travel medicine.
[3] D. Shepard,et al. The potential impact of dengue vaccination with, and without, pre-vaccination screening. , 2019, Vaccine.
[4] A. Ko,et al. Zika Virus Infection - After the Pandemic. , 2019, The New England journal of medicine.
[5] D. Cummings,et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region , 2019, Science.
[6] T. Pierson,et al. The emergence of Zika virus and its new clinical syndromes , 2018, Nature.
[7] A. Trkola,et al. Development of a high-throughput bead based assay system to measure HIV-1 specific immune signatures in clinical samples. , 2017, Journal of immunological methods.
[8] Karen G. Dowell,et al. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles , 2017, Journal of immunological methods.
[9] Scott C Weaver,et al. Epidemic arboviral diseases: priorities for research and public health. , 2017, The Lancet. Infectious diseases.
[10] E. Gould,et al. ICTV Virus Taxonomy Profile: Flaviviridae , 2017, The Journal of general virology.
[11] Anavaj Sakuntabhai,et al. Structural basis of potent Zika–dengue virus antibody cross-neutralization , 2016, Nature.
[12] Anthony S Fauci,et al. Zika Virus in the Americas--Yet Another Arbovirus Threat. , 2016, The New England journal of medicine.
[13] Tormod Fladby,et al. A Practical Guide to Immunoassay Method Validation , 2015, Front. Neurol..
[14] Richard J. Kuhn,et al. Combined Effects of the Structural Heterogeneity and Dynamics of Flaviviruses on Antibody Recognition , 2014, Journal of Virology.
[15] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[16] K. Stiasny,et al. Flaviviruses and their antigenic structure. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] Cameron P. Simmons,et al. Current concepts: Dengue , 2012 .
[18] R. Lanciotti,et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. , 2009, The New England journal of medicine.
[19] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[20] D. Fremont,et al. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. , 2008, Cell host & microbe.
[21] T. Pierson,et al. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection , 2008, Expert Reviews in Molecular Medicine.
[22] G. Kuno,et al. Phylogeny of the Genus Flavivirus , 1998, Journal of Virology.
[23] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[24] N. Karabatsos,et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.